Adherence to deferoxamine therapy: heeding Hippocrates and Osler

Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997-2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR).

Cancer treatment and research·2022

Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study.

The Lancet. Global health·2021

Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.

Acta haematologica·2021

Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.

PloS one·2019

Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.

British journal of haematology·2015

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

Blood·2014

Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management.

American journal of hematology·2026

Navigating Asparaginase Treatment for Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations on the Role of Multidisciplinary Care.

American journal of hematology·2026

Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study.

American journal of hematology·2026

2026 Update on Clinical Trials in β-Thalassemia.

American journal of hematology·2026

Monoclonal Gammopathy of Thrombotic Significance.

American journal of hematology·2026

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

American journal of hematology·2026

Stress Perfusion CMR to Prognosticate for Left Main and High Risk Multivessel Coronary Artery Disease and Major Cardiovascular Adverse Events: Outcomes From a 4,144-Patient Multicenter Cohort.

JACC. Cardiovascular imaging·2026

Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Cardiovascular, Renal, and Pulmonary Risks of Long COVID: A Retrospective Cohort Study Stratified by Age and Sex.

Journal of the American Heart Association·2026

Association of Myeloperoxidase and Granulocyte Colony-Stimulating Factor With Intracranial Atherosclerosis Presence and Progression From a Community-Based Study.

Journal of the American Heart Association·2026

Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Journal of the American Heart Association·2026

Genetic Research on Cardiac Channelopathies in African and African-Descent Populations: A Scoping Review.

Journal of the American Heart Association·2026

Related Experiment Videos

Adherence to deferoxamine therapy: heeding Hippocrates and Osler

Related Concept Videos

Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997-2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR).

Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study.

Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.

Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.

Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management.

Navigating Asparaginase Treatment for Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations on the Role of Multidisciplinary Care.

Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study.

2026 Update on Clinical Trials in β-Thalassemia.

Monoclonal Gammopathy of Thrombotic Significance.

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

Stress Perfusion CMR to Prognosticate for Left Main and High Risk Multivessel Coronary Artery Disease and Major Cardiovascular Adverse Events: Outcomes From a 4,144-Patient Multicenter Cohort.

Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality.

Cardiovascular, Renal, and Pulmonary Risks of Long COVID: A Retrospective Cohort Study Stratified by Age and Sex.

Association of Myeloperoxidase and Granulocyte Colony-Stimulating Factor With Intracranial Atherosclerosis Presence and Progression From a Community-Based Study.

Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Genetic Research on Cardiac Channelopathies in African and African-Descent Populations: A Scoping Review.

Related Experiment Videos

Adherence to deferoxamine therapy: heeding Hippocrates and Osler

Related Concept Videos

Related Articles